Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000464001 | SCV000542609 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2018-01-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001571115 | SCV001795530 | likely benign | not provided | 2019-06-07 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001571115 | SCV003819193 | uncertain significance | not provided | 2019-06-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004735532 | SCV005363020 | uncertain significance | TTN-related disorder | 2024-04-09 | no assertion criteria provided | clinical testing | The TTN c.44848G>A variant is predicted to result in the amino acid substitution p.Asp14950Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0087% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |